Aehr Test Systems
AEHR · NASDAQ
5/31/2025 | 5/30/2025 | 5/31/2024 | 5/31/2023 | |
|---|---|---|---|---|
| Revenue | $59 | – | $66 | $65 |
| % Growth | – | – | 1.9% | – |
| Cost of Goods Sold | $35 | – | $34 | $32 |
| Gross Profit | $24 | – | $33 | $33 |
| % Margin | 40.6% | – | 49.1% | 50.4% |
| R&D Expenses | $10 | – | $9 | $7 |
| G&A Expenses | $0 | – | $0 | $0 |
| SG&A Expenses | $18 | – | $14 | $12 |
| Sales & Mktg Exp. | $0 | – | $0 | $0 |
| Other Operating Expenses | $0 | – | $0 | $0 |
| Operating Expenses | $28 | – | $22 | $19 |
| Operating Income | -$4 | – | $10 | $13 |
| % Margin | -7.3% | – | 15.2% | 20.6% |
| Other Income/Exp. Net | $0 | – | $2 | $1 |
| Pre-Tax Income | -$4 | – | $12 | $15 |
| Tax Expense | -$0 | – | -$21 | $0 |
| Net Income | -$4 | – | $33 | $15 |
| % Margin | -6.6% | – | 50.1% | 22.4% |
| EPS | -0.13 | – | 1.151 | 0.524 |
| % Growth | – | – | 119.6% | – |
| EPS Diluted | -0.13 | – | 1.12 | 0.498 |
| Weighted Avg Shares Out | 30 | – | 29 | 28 |
| Weighted Avg Shares Out Dil | 30 | – | 30 | 29 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | – | $2 | $1 |
| Interest Expense | $0 | – | $0 | $0 |
| Depreciation & Amortization | $3 | – | $1 | $0 |
| EBITDA | -$1 | – | $14 | $15 |
| % Margin | -1.5% | – | 20.9% | 23.2% |